NCI-DOE Collaboration Paving Way for Large-Scale Computational Cancer Science

| October 9, 2017 | 0 Comments
NCI-DOE Collaboration Paving Way for Large-Scale Computational Cancer Science

NCI and the Department of Energy have entered into a collaboration to develop a plan to use large-scale computing to influence cancer science and, ultimately, clinical treatment.
See Original Article

Ibrutinib Becomes First FDA-Approved Drug for Chronic Graft-Versus-Host Disease

A drug used to treat several blood cancers, ibrutinib, has been approved by FDA to treat chronic graft-versus-host disease, making it the first approved therapy for this potentially fatal side effect of cancer-related stem cell transplants.
See Original Article

FDA Approves Niraparib as Maintenance Therapy for Recurrent Ovarian Cancer

The FDA approved the PARP inhibitor niraparib for use as a maintenance therapy for some women with advanced ovarian cancer.
See Original Article

Category: Recent News

About the Author ()

Leave a Reply